2372 Stock Overview
Engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
I'rom Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,596.00 |
| 52 Week High | JP¥2,790.00 |
| 52 Week Low | JP¥1,750.00 |
| Beta | 0.37 |
| 11 Month Change | -6.59% |
| 3 Month Change | -6.35% |
| 1 Year Change | 34.44% |
| 33 Year Change | 44.38% |
| 5 Year Change | 80.15% |
| Change since IPO | -35.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2372 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.5% | -1.3% | -0.4% |
| 1Y | 34.4% | -6.5% | 11.4% |
Return vs Industry: 2372 exceeded the JP Healthcare industry which returned -6.5% over the past year.
Return vs Market: 2372 exceeded the JP Market which returned 11.4% over the past year.
Price Volatility
| 2372 volatility | |
|---|---|
| 2372 Average Weekly Movement | 1.8% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2372 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2372's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,029 | Toyotaka Mori | www.iromgroup.co.jp |
I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the research and development of pharmaceuticals and medical technologies; cell banking business; and contract manufacturing of products that applies medical technology to cosmetics, etc. It also supports medical institutions in conducting clinical trials; provides substitution and support for the work of pharmaceutical companies and academia that are involved in clinical research, including clinical trials of pharmaceuticals, medical devices, regenerative medicine, and other products; and operates clinic malls and other facilities. The company was formerly known as I'Rom Holdings Co., Ltd.
I'rom Group Co., Ltd. Fundamentals Summary
| 2372 fundamental statistics | |
|---|---|
| Market cap | JP¥31.43b |
| Earnings (TTM) | JP¥258.00m |
| Revenue (TTM) | JP¥17.89b |
121.8x
P/E Ratio1.8x
P/S RatioIs 2372 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2372 income statement (TTM) | |
|---|---|
| Revenue | JP¥17.89b |
| Cost of Revenue | JP¥10.80b |
| Gross Profit | JP¥7.09b |
| Other Expenses | JP¥6.83b |
| Earnings | JP¥258.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 21.31 |
| Gross Margin | 39.63% |
| Net Profit Margin | 1.44% |
| Debt/Equity Ratio | 135.7% |
How did 2372 perform over the long term?
See historical performance and comparison